Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Inovio Pharmaceuticals Inc (NASDAQ: INO) closed at $1.89 in the last session, down -2.58% from day before closing price of $1.94. In other words, the price has decreased by -$2.58 from its previous closing price. On the day, 0.78 million shares were traded. INO stock price reached its highest trading level at $1.94 during the session, while it also had its lowest trading level at $1.82.
Ratios:
We take a closer look at INO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.77 and its Current Ratio is at 2.77. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.14.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on May 14, 2024, initiated with a Overweight rating and assigned the stock a target price of $20.
On January 25, 2024, Oppenheimer Upgraded its rating to Outperform which previously was Perform but kept the price unchanged to $4.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INO now has a Market Capitalization of 69312912 and an Enterprise Value of -11113933. For the stock, the TTM Price-to-Sale (P/S) ratio is 315.07 while its Price-to-Book (P/B) ratio in mrq is 1.00. Its current Enterprise Value per Revenue stands at -51.038 whereas that against EBITDA is 0.1.
Stock Price History:
The Beta on a monthly basis for INO is 1.41, which has changed by -0.8438016 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, INO has reached a high of $13.44, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is 2.08%, while the 200-Day Moving Average is calculated to be -56.79%.
Shares Statistics:
According to the various share statistics, INO traded on average about 676.98K shares per day over the past 3-months and 446360 shares per day over the past 10 days. A total of 36.67M shares are outstanding, with a floating share count of 36.42M. Insiders hold about 0.69% of the company’s shares, while institutions hold 36.67% stake in the company. Shares short for INO as of 1744675200 were 6679286 with a Short Ratio of 9.87, compared to 1741910400 on 5354671. Therefore, it implies a Short% of Shares Outstanding of 6679286 and a Short% of Float of 18.34.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The stock of Inovio Pharmaceuticals Inc (INO) is currently in the spotlight, with 4.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.68, with high estimates of -$0.55 and low estimates of -$0.85.
Analysts are recommending an EPS of between -$2.12 and -$2.96 for the fiscal current year, implying an average EPS of -$2.61. EPS for the following year is -$2.35, with 4.0 analysts recommending between -$1.37 and -$3.25.
Revenue Estimates
Based on 5 analysts’ estimates, the company’s revenue will be $21.6M in the next fiscal year. The high estimate is $58.66M and the low estimate is $9.9M.
